SIRT1: A Promising Therapeutic Target for Chronic Pain
Overview
Authors
Affiliations
Chronic pain remains an unresolved problem. Current treatments have limited efficacy. Thus, novel therapeutic targets are urgently required for the development of more effective analgesics. An increasing number of studies have proved that sirtuin 1 (SIRT1) agonists can relieve chronic pain. In this review, we summarize recent progress in understanding the roles and mechanisms of SIRT1 in mediating chronic pain associated with peripheral nerve injury, chemotherapy-induced peripheral neuropathy, spinal cord injury, bone cancer, and complete Freund's adjuvant injection. Emerging studies have indicated that SIRT1 activation may exert positive effects on chronic pain relief by regulating inflammation, oxidative stress, and mitochondrial dysfunction. Therefore, SIRT1 agonists may serve as potential therapeutic drugs for chronic pain.
Yuan C, Wang X, Liu Y, Xu T, Yu Z, Xu B World J Diabetes. 2025; 16(2):93130.
PMID: 39959279 PMC: 11718478. DOI: 10.4239/wjd.v16.i2.93130.
Li J, Cui S, Li Y, Zhang C, Chang C, Jian F CNS Neurosci Ther. 2025; 31(2):e70244.
PMID: 39915897 PMC: 11802336. DOI: 10.1111/cns.70244.
Zhang L, Zhao F, Li Y, Song Z, Hu L, Li Y Redox Biol. 2025; 79():103472.
PMID: 39752998 PMC: 11754494. DOI: 10.1016/j.redox.2024.103472.
Role of epigenetics in corneal health and disease.
Sood S, Tiwari A, Sangwan J, Vohra M, Sinha N, Tripathi R Prog Retin Eye Res. 2024; 104():101318.
PMID: 39547455 PMC: 11710990. DOI: 10.1016/j.preteyeres.2024.101318.
Battling pain from osteoarthritis: causing novel cell death.
Zhang Y, Tao H, Zhang L, Li X, Shi Y, Sun W Acta Biochim Biophys Sin (Shanghai). 2024; 57(2):169-181.
PMID: 39463202 PMC: 11877141. DOI: 10.3724/abbs.2024189.